K A Krueger - JoVE Visualize

Showing results (1-10 of 11) with videos related to

Pageof 2

Sort By:

The Journal of Biological Chemistry|October 27, 1997

Calcium-stimulated phosphorylation of MAP-2 in pancreatic betaTC3-cells is mediated by Ca2+/calmodulin-dependent kinase IIK A Krueger, H Bhatt, M Landt, et al.

The American Journal of Emergency Medicine|September 1, 1985

Hypokalemia, hyperglycemia, and acidosis after intentional theophylline overdoseW T Sawyer, E M Caravati, M J Ellison, et al.

Diabetes|March 17, 1999

Site-specific phosphorylation of synapsin I by Ca2+/calmodulin-dependent protein kinase II in pancreatic betaTC3 cells: synapsin I is not associated with insulin secretory granulesK A Krueger, E I Ings, A M Brun, et al.

Journal of Thrombosis and Haemostasis : JTH|April 6, 2007

A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacementG Agnelli, S Haas, J S Ginsberg, et al.

Epilepsia|November 1, 1987

Effect of two administration schedules of an enteral nutrient formula on phenytoin bioavailabilityK A Krueger, W R Garnett, T J Comstock, et al.

Endocrinology|December 1, 1990

Testosterone differentially modulates gonadotropin subunit messenger ribonucleic acid responses to gonadotropin-releasing hormone pulse amplitudeS A Iliff-Sizemore, G A Ortolano, D J Haisenleder, et al.

CPT: Pharmacometrics & Systems Pharmacology|January 24, 2014

The pharmacokinetics and pharmacokinetic/pharmacodynamic relationships of evacetrapib administered as monotherapy or in combination with statinsS Friedrich, J J P Kastelein, D James, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001

Indicators of lifetime estrogen exposure: effect on breast cancer incidence and interaction with raloxifene therapy in the multiple outcomes of raloxifene evaluation study participantsM E Lippman, K A Krueger, S Eckert, et al.

Circulation|August 1, 1996

Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Results of a randomized, double-blind, placebo-controlled trialG L Schaer, L J Spaccavento, K F Browne, et al.

JAMA|June 22, 1999

The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene EvaluationS R Cummings, S Eckert, K A Krueger, et al.

Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:

Pageof 2

The Journal of Biological Chemistry|October 27, 1997

Calcium-stimulated phosphorylation of MAP-2 in pancreatic betaTC3-cells is mediated by Ca2+/calmodulin-dependent kinase IIK A Krueger, H Bhatt, M Landt, et al.

The American Journal of Emergency Medicine|September 1, 1985

Hypokalemia, hyperglycemia, and acidosis after intentional theophylline overdoseW T Sawyer, E M Caravati, M J Ellison, et al.

Diabetes|March 17, 1999

Site-specific phosphorylation of synapsin I by Ca2+/calmodulin-dependent protein kinase II in pancreatic betaTC3 cells: synapsin I is not associated with insulin secretory granulesK A Krueger, E I Ings, A M Brun, et al.

Journal of Thrombosis and Haemostasis : JTH|April 6, 2007

A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacementG Agnelli, S Haas, J S Ginsberg, et al.

Epilepsia|November 1, 1987

Effect of two administration schedules of an enteral nutrient formula on phenytoin bioavailabilityK A Krueger, W R Garnett, T J Comstock, et al.

Endocrinology|December 1, 1990

Testosterone differentially modulates gonadotropin subunit messenger ribonucleic acid responses to gonadotropin-releasing hormone pulse amplitudeS A Iliff-Sizemore, G A Ortolano, D J Haisenleder, et al.

CPT: Pharmacometrics & Systems Pharmacology|January 24, 2014

The pharmacokinetics and pharmacokinetic/pharmacodynamic relationships of evacetrapib administered as monotherapy or in combination with statinsS Friedrich, J J P Kastelein, D James, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001

Indicators of lifetime estrogen exposure: effect on breast cancer incidence and interaction with raloxifene therapy in the multiple outcomes of raloxifene evaluation study participantsM E Lippman, K A Krueger, S Eckert, et al.

Circulation|August 1, 1996

Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Results of a randomized, double-blind, placebo-controlled trialG L Schaer, L J Spaccavento, K F Browne, et al.

JAMA|June 22, 1999

The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene EvaluationS R Cummings, S Eckert, K A Krueger, et al.

Pageof 2